CYP24A1 and colitis: Oral administration of hCA I reproducibly suppressed colitis and weight loss in vivo (Figs. 1 and 5), as well as the production of inflammatory cytokines and suppression of transcripts related to inflammation in vitro (Figs. 2, 6, and 7).